Literature DB >> 23384620

Plasmodium vivax: modern strategies to study a persistent parasite's life cycle.

Mary R Galinski1, Esmeralda V S Meyer, John W Barnwell.   

Abstract

Plasmodium vivax has unique attributes to support its survival in varying ecologies and climates. These include hypnozoite forms in the liver, an invasion preference for reticulocytes, caveola-vesicle complex structures in the infected erythrocyte membrane and rapidly forming and circulating gametocytes. These characteristics make this species very different from P. falciparum. Plasmodium cynomolgi and other related simian species have identical biology and can serve as informative models of P. vivax infections. Plasmodium vivax and its model parasites can be grown in non-human primates (NHP), and in short-term ex vivo cultures. For P. vivax, in the absence of in vitro culture systems, these models remain highly relevant side by side with human clinical studies. While post-genomic technologies allow for greater exploration of P. vivax-infected blood samples from humans, these come with restrictions. Two advantages of NHP models are that infections can be experimentally tailored to address hypotheses, including genetic manipulation. Also, systems biology approaches can capitalise on computational biology combined with set experimental infection periods and protocols, which may include multiple sampling times, different types of samples, and the broad use of "omics" technologies. Opportunities for research on vivax malaria are increasing with the use of existing and new methodological strategies in combination with modern technologies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23384620     DOI: 10.1016/B978-0-12-407826-0.00001-1

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  32 in total

Review 1.  From within host dynamics to the epidemiology of infectious disease: Scientific overview and challenges.

Authors:  Juan B Gutierrez; Mary R Galinski; Stephen Cantrell; Eberhard O Voit
Journal:  Math Biosci       Date:  2015-10-16       Impact factor: 2.144

Review 2.  Malaria vaccine clinical trials: what's on the horizon.

Authors:  Alberto Moreno; Chester Joyner
Journal:  Curr Opin Immunol       Date:  2015-07-13       Impact factor: 7.486

Review 3.  Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.

Authors:  Alexis Kaushansky; Sebastian A Mikolajczak; Marissa Vignali; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

4.  Malarial liver parasites awaken in culture.

Authors:  John W Barnwell; Mary R Galinski
Journal:  Nat Med       Date:  2014-03       Impact factor: 53.440

Review 5.  Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.

Authors:  Brice Campo; Omar Vandal; David L Wesche; Jeremy N Burrows
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

6.  Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.

Authors:  Sebastian A Mikolajczak; Ashley M Vaughan; Niwat Kangwanrangsan; Wanlapa Roobsoong; Matthew Fishbaugher; Narathatai Yimamnuaychok; Nastaran Rezakhani; Viswanathan Lakshmanan; Naresh Singh; Alexis Kaushansky; Nelly Camargo; Michael Baldwin; Scott E Lindner; John H Adams; Jetsumon Sattabongkot; Jetsumon Prachumsri; Stefan H I Kappe
Journal:  Cell Host Microbe       Date:  2015-03-19       Impact factor: 21.023

7.  Zoonotic Transmissions and Host Switches of Malaria Parasites.

Authors:  Xin-Zhuan Su; Jian Wu
Journal:  Zoonoses (Burlingt)       Date:  2021-11-02

Review 8.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

Review 9.  Malaria in India: The Need for New Targets for Diagnosis and Detection of Plasmodium vivax.

Authors:  Swati Patankar; Shobhona Sharma; Pradipsinh K Rathod; Manoj T Duraisingh
Journal:  Proteomics Clin Appl       Date:  2018-01-11       Impact factor: 3.494

10.  Plasmodium vivax trophozoite-stage proteomes.

Authors:  D C Anderson; Stacey A Lapp; Sheila Akinyi; Esmeralda V S Meyer; John W Barnwell; Cindy Korir-Morrison; Mary R Galinski
Journal:  J Proteomics       Date:  2014-12-27       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.